Health ❯ Pharmaceuticals ❯ Drug Regulation

FDA

Compounding Pharmacies Leadership Changes Compounded Drugs Enforcement Orders Tirzepatide Bladder Cancer Nasal Decongestants Class II Recall Paracetamol Oral Decongestants George Tidmarsh Leadership Over-the-Counter Medications Online Drug Services Oral Phenylephrine Weight Loss Medications Peptide Therapies Carcinogens

ImmunityBio Investors Face May 26 Lead-Plaintiff Deadline in Securities Suit Tied to FDA Anktiva Rebuke

The case stems from an FDA warning that promotional claims for Anktiva were false or misleading, which drove a roughly 21% stock drop on March 24.

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

FDA Flags Possible License Revocation for Sarepta’s Elevidys

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research